Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.55
+0.12 (2.21%)
Sep 18, 2026, 4:08 PM HKT

HKG:0719 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
215.26289.89470.02496.51411.06348.55
Depreciation & Amortization
580.91587.52540.95516.94489.4438.58
Other Amortization
33.814.354.733.322.752.48
Loss (Gain) From Sale of Assets
-0.37-1.99-1.42-8.73-5.54-2.07
Asset Writedown & Restructuring Costs
2.351.115.12-33.26-39.29-84.79
Loss (Gain) From Sale of Investments
-9.36-7.76-9.84-9.58-8.36-8.02
Provision & Write-off of Bad Debts
4.096.28.4910.735.242.32
Other Operating Activities
87.3498.0993.93121.24122.3797.65
Change in Accounts Receivable
-358.17-547.75-629.94-423.54-717.33-751.07
Change in Inventory
-104.63-92.83-11.43-120.86-200.1476.18
Change in Accounts Payable
11.73184.72-153.63-332.39632.33121.63
Change in Other Net Operating Assets
6.1112.5235.8853.0745.83.96
Operating Cash Flow
460.21533.73367.61265.28758.24259.12
Operating Cash Flow Growth
-12.23%45.19%38.57%-65.01%192.63%-38.33%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-78.47-115.6-212.42-325.13-244.76-249.23
Sale of Property, Plant & Equipment
1.070.770.6511.867.942.43
Investment in Securities
4.731.53-8.63---
Other Investing Activities
6.689.88.188.177.929.11
Investing Cash Flow
-65.98-103.5-212.21-305.11-228.9-237.69

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-979.8860.31862.43833.79551.41
Long-Term Debt Repaid
--1,114-554.05-888.15-1,106-603.48
Lease Payments
-2.1-1.84-1.99-2.7-17.69-43.74
Net Debt Issued (Repaid)
-40.31-133.72306.26-25.72-272.57-52.07
Issuance of Common Stock
45.9453.1763.266.02274.6932.97
Common Dividends Paid
-207.09-209.78-225.85-175.9-163.01-148.43
Other Financing Activities
39.18-0.841.11-0.530.2427.8
Financing Cash Flow
-162.28-291.13184.78-196.11-130.66-139.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-5.427.2415.016.8615.69-7.87
Net Cash Flow
226.53146.33355.19-229.08414.37-126.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
381.74418.13155.19-59.85513.489.89
Free Cash Flow Growth
14.89%169.43%--5092.02%-92.94%
Free Cash Flow Margin
4.50%4.78%1.83%-0.74%6.84%0.15%
Free Cash Flow Per Share
0.550.600.23-0.090.770.02
Levered Free Cash Flow
467.31654.46551.1250.07779.34222.79
Unlevered Free Cash Flow
491.22680.98575.9675.79810.41255.98
Free Cash Flow After Leases
379.64416.29153.2-62.55495.79-33.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
165.52142.596.2239.7966.2544.5
Change in Working Capital
-453.81-443.67-744.37-831.87-219.39-535.59